Dr. Gregory Day

Dr. Day completed his Neurology residency at the University of Toronto, before moving to Saint Louis (Missouri) to complete a post-doctoral fellowship in dementia. He is currently an Assistant Professor within the Department of Neurology at Washington University in St. Louis, and an Associate Director of the Knight Alzheimer Disease Research Center Clinical Core. His research focuses on characterizing the clinical presentation and improving treatments for patients with anti-NMDA-receptor encephalitis and related diseases, with an emphasis on improving long-term cognitive outcomes.  Dr. Day is a founding member of the Anti-NMDA Receptor Encephalitis Foundation, and serves as the Clinical Director.